
Core Viewpoint - Origin Agritech Ltd. reported a decrease in revenue for the first half of fiscal year 2025, primarily due to production halts and equipment upgrades, while highlighting significant advancements in biotechnology and strategic partnerships aimed at long-term growth [6][13]. Business Accomplishments and Highlights - Established the "Origin Marker Biological Breeding Service Consortium" in October 2024 to enhance the commercialization of GMO traits and gene editing technologies, collaborating with numerous breeding companies across China [5]. - Formed a three-way partnership with China Agricultural University and the Beijing Academy of Agricultural and Forestry Sciences in January 2025 to focus on corn improvement and innovative variety development [5]. - Signed cooperation agreements with 12 agricultural companies during a seminar in January 2025, focusing on biotechnology services and transgenic applications [5]. - Advanced GMO corn hybrid trials, with one hybrid on track for potential approval in 2025 and two others expected in 2026 [5]. - Launched the MIGC 20K gene chip technology in January 2025, enhancing molecular breeding capabilities [5]. - Established four R&D platforms and accumulated nearly 300,000 corn germplasm resources, receiving authorization for multiple gene editing traits [5]. Financial Results - Revenue for the six months ended March 31, 2025, was $10.1 million, down from $13.0 million in the same period of 2024, attributed to production capacity reductions [6]. - Total operating expenses increased to $4.6 million from $1.9 million year-over-year, with general and administrative expenses rising significantly [7][8]. - The company reported an operating loss of $3.4 million compared to an operating income of $0.6 million in the previous year [9]. - Net loss attributable to the company was $3.6 million, a decline from a net profit of $0.2 million a year ago, with a loss per share of $0.50 compared to an income per share of $0.03 [10][11]. Management Commentary - The CEO emphasized the transformative period for the company, focusing on strategic investments and the establishment of a three-platform strategy aimed at long-term value creation [13].